Logo image of BKYI

BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

NASDAQ:BKYI - Nasdaq - US09060C5076 - Common Stock - Currency: USD

1.06  -0.02 (-1.85%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BKYI. BKYI was compared to 281 industry peers in the Software industry. BKYI may be in some trouble as it scores bad on both profitability and health. BKYI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BKYI had negative earnings in the past year.
BKYI had a negative operating cash flow in the past year.
BKYI had negative earnings in each of the past 5 years.
In the past 5 years BKYI always reported negative operating cash flow.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

BKYI has a Return On Assets of -142.02%. This is amonst the worse of the industry: BKYI underperforms 91.17% of its industry peers.
BKYI has a Return On Equity of -6833.91%. This is amonst the worse of the industry: BKYI underperforms 86.93% of its industry peers.
Industry RankSector Rank
ROA -142.02%
ROE -6833.91%
ROIC N/A
ROA(3y)-107.41%
ROA(5y)-189.86%
ROE(3y)-352.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 14.78%, BKYI is doing worse than 85.87% of the companies in the same industry.
In the last couple of years the Gross Margin of BKYI has declined.
The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.43%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BKYI has been reduced compared to 1 year ago.
BKYI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BKYI has an improved debt to assets ratio.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -31.64, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
BKYI has a worse Altman-Z score (-31.64) than 94.35% of its industry peers.
BKYI has a Debt/Equity ratio of 16.91. This is a high value indicating a heavy dependency on external financing.
BKYI has a worse Debt to Equity ratio (16.91) than 86.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 16.91
Debt/FCF N/A
Altman-Z -31.64
ROIC/WACCN/A
WACC14.19%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

BKYI has a Current Ratio of 0.78. This is a bad value and indicates that BKYI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.78, BKYI is doing worse than 84.45% of the companies in the same industry.
A Quick Ratio of 0.71 indicates that BKYI may have some problems paying its short term obligations.
The Quick ratio of BKYI (0.71) is worse than 84.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.71
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BKYI have decreased strongly by -344.97% in the last year.
Looking at the last year, BKYI shows a very negative growth in Revenue. The Revenue has decreased by -25.56% in the last year.
BKYI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.93% yearly.
EPS 1Y (TTM)-344.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.06%
Revenue 1Y (TTM)-25.56%
Revenue growth 3Y39.77%
Revenue growth 5Y13.93%
Sales Q2Q%18.03%

3.2 Future

BKYI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.91% yearly.
Based on estimates for the next years, BKYI will show a decrease in Revenue. The Revenue will decrease by -7.80% on average per year.
EPS Next Y-113.79%
EPS Next 2Y-33.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.48%
Revenue Next 2Y-7.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKYI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKYI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

BKYI's earnings are expected to decrease with -33.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.91%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BKYI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (3/7/2025, 8:07:50 PM)

1.06

-0.02 (-1.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-31 2025-03-31/bmo
Inst Owners2.05%
Inst Owner Change-75.64%
Ins Owners4.76%
Ins Owner Change0.22%
Market Cap3.84M
Analysts82.86
Price Target3.06 (188.68%)
Short Float %2.44%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.74%
Min EPS beat(2)-81.55%
Max EPS beat(2)34.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.6%
Min Revenue beat(2)-42.62%
Max Revenue beat(2)31.42%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 28.85
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.12
EYN/A
EPS(NY)-1.59
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS1.77
BVpS0.04
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -142.02%
ROE -6833.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.78%
FCFM N/A
ROA(3y)-107.41%
ROA(5y)-189.86%
ROE(3y)-352.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.43%
GM growth 5YN/A
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 16.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.06%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.71
Altman-Z -31.64
F-Score3
WACC14.19%
ROIC/WACCN/A
Cap/Depr(3y)11.68%
Cap/Depr(5y)11.43%
Cap/Sales(3y)0.65%
Cap/Sales(5y)0.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-344.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.06%
EPS Next Y-113.79%
EPS Next 2Y-33.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.56%
Revenue growth 3Y39.77%
Revenue growth 5Y13.93%
Sales Q2Q%18.03%
Revenue Next Year-22.48%
Revenue Next 2Y-7.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.6%
OCF growth 3YN/A
OCF growth 5YN/A